1 |
Bocher O, Ludwig TE, Oglobinsky M, Marenne G, Deleuze J, Suryakant S, Odeberg J, Morange P, Trégouët D, Perdry H, Génin E. Testing for association with rare variants in the coding and non-coding genome: RAVA-FIRST, a new approach based on CADD deleteriousness score. PLoS Genet 2022;18:e1009923. [DOI: 10.1371/journal.pgen.1009923] [Reference Citation Analysis]
|
2 |
Xu W, Deng M, Meng X, Sun X, Tao X, Wang D, Zhang S, Zhen Y, Liu X, Liu M. The alterations in molecular markers and signaling pathways in chronic thromboembolic pulmonary hypertension, a study with transcriptome sequencing and bioinformatic analysis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.961305] [Reference Citation Analysis]
|
3 |
Feng R, Lu M, Yang Y, Luo P, Liu L, Xu K, Xu P. Genome- and transcriptome-wide association studies show that pulmonary embolism is associated with bone-forming proteins. Expert Rev Hematol 2022. [PMID: 35848930 DOI: 10.1080/17474086.2022.2103534] [Reference Citation Analysis]
|
4 |
Edfors F, Iglesias MJ, Butler LM, Odeberg J. Proteomics in thrombosis research. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12706] [Reference Citation Analysis]
|
5 |
Bocher O, Ludwig TE, Marenne G, Deleuze J, Suryakant S, Odeberg J, Morange P, Trégouët D, Perdry H, Génin E. Testing for association with rare variants in the coding and non-coding genome: RAVA-FIRST, a new approach based on CADD deleteriousness score.. [DOI: 10.1101/2021.11.04.467235] [Reference Citation Analysis]
|